×

Register now for full access to all the content

First Name
Last Name
Company Name
Title
Country
Thank you for registering!
Error - something went wrong!

PAREXEL on Japan Market Access

March 23, 2012
http://www.PAREXEL.com Alberto Grignolo, PAREXEL Corporate VP of Global Strategy shares the reasons why foreign companies should enter the pharmaceutical market in Japan. He discusses how Japan's appetite for innovation in drug development and recent regulations have created a favorable business environment and improved market access opportunities. For more videos, go to http://www.parexel.com/news-and-events/video-series/
Previous Video
Video of Dr. Goldberg, recorded at Partnerships in Clinical Trials
Video of Dr. Goldberg, recorded at Partnerships in Clinical Trials

Mark A. Goldberg, M.D., Chief Operating Officer of PAREXEL, discusses marketplace pressures and how clinica...

No More Videos